PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jcmPermissionsJournals.ASM.orgJournalJCM ArticleJournal InfoAuthorsReviewers
 
J Clin Microbiol. 2009 October; 47(10): 3358–3361.
Published online 2009 August 26. doi:  10.1128/JCM.01093-09
PMCID: PMC2756927

Implanted-Port-Catheter-Related Sepsis Caused by Acidovorax avenae and Methicillin-Sensitive Staphylococcus aureus[down-pointing small open triangle]

Abstract

Acidovorax avenae is a gram-negative rod in the family Comamonadaceae and a phytopathogen found in the environment. Human infections caused by members of the Comamonadaceae are extremely rare. We report a case of implanted-port-catheter-related sepsis caused by Acidovorax avenae and methicillin (meticillin)-sensitive Staphylococcus aureus (MSSA).

CASE REPORT

A 27-year-old-white female with severe iron deficiency anemia underwent implantation of a central venous infusion port catheter 2 months previously for intravenous iron replacement therapy. The etiology of the anemia was thought to be secondary to multiple bowel surgeries for chronic abdominal pain. Six weeks after port placement, she developed fever (39.4°C) associated with shaking chills, nausea, vomiting, and diarrhea. She visited the emergency department, where two blood cultures were drawn, but refused hospital admission. She continued to tolerate worsening symptoms at home for the next 5 days. The two blood cultures previously drawn in the emergency department grew methicillin (meticillin)-sensitive Staphylococcus aureus (MSSA), and the patient was urged to return to the hospital. She agreed to the admission.

She was febrile to 40.3°C and tachycardic at 125 beats per minute and had a blood pressure of 100/60 mm Hg. Physical examination revealed a pale Caucasian female in moderate distress with a palpable subcutaneous device located in the right superior-anterior chest. There was no erythema, swelling, tenderness, or other pertinent physical examination findings. She had a normal white blood cell count of 9.1 × 109/μl and a hemoglobin level of 7.7 g/dl. A diagnosis of sepsis was made. Antibiotics were started with daptomycin 500 mg intravenously once daily and cefazolin 1 g intravenously every 8 h. The port catheter was suspected as the source of sepsis, and surgical consultation was sought.

On hospital day 3, the patient underwent removal of the port catheter. At the time of port-catheter removal, purulent exudate was seen to exit from the accessed skin site. Preliminary culture results for this device revealed both gram-positive cocci (GPC) and gram-negative rods (GNRs). The patient remained febrile, and two blood cultures obtained later that day revealed solely GNRs. Gentamicin was added at this time to broaden coverage. Finally, on postoperative day 3, the patient defervesced. One subsequent blood culture documented sterility of the bloodstream. On postoperative day 7, a peripherally inserted central catheter was placed for further antibiotic therapy. The patient developed a mild erythematous rash thought to be secondary to beta-lactam allergy; therefore, antibiotic therapy was changed to vancomycin and gentamicin. The patient successfully completed 8 more days of treatment.

Blood cultures (Table (Table1)1) were obtained aseptically from different venipuncture sites by using BacT/Alert SA culture bottles (bioMérieux Inc., Durham, NC). After 17 h of incubation at 37°C, both blood cultures were positive and were then plated aerobically at 37°C in 5% CO2 (MacConkey II, TSA II 5% sheep blood, and Chocolate II agar plates). Simultaneously, anaerobic cultures were plated on CDC anaerobe 5% sheep blood agar and CDC anaerobe laked sheep blood agar with kanamycin and vancomycin (BBL prepared culture media; Becton, Dickinson and Company, Sparks, MD) and incubated at 37°C in an anaerobic chamber.

TABLE 1.
Culture timeline during hospital course

The catheter tip was plated on chocolate, MacConkey II, and thioglycolate medium enriched with vitamin K1 and hemin (BBL prepared culture media; Becton, Dickinson and Company, Sparks, MD) and incubated at 37°C in 5% CO2. Phenotypic identification and susceptibility testing were performed with Vitek 2 compact gram-negative identification and AST-GN15 sensitivity cards (bioMérieux Inc., Durham, NC). An additional commercial diagnostic system, bioMérieux API 20E, was set up on all three isolates, according to the manufacturer's instructions. Susceptibility tests were performed by the gradient diffusion method (Etest; AB Biodisk North America, Inc., Piscataway, NJ).

The GNR isolate was sent to the University of Washington Medical Center for 16S rRNA nucleic acid sequencing. Conclusive identification of the organism was based on comparing the nucleic acid sequence alignment using Basic Local Alignment Search Tool (BLAST) with databases at the National Center for Biotechnology Information (NCBI) and sequence-based phylogenic trees (bacterial sequencing database, University of Washington Laboratory Medicine, Seattle, WA, 2007 [http://depts.washington.edu/molmicdx/mdx/tests/bctseq.shtml]).

The GNR culture plates showed small colonies, approximately 1 mm in diameter, under aerobic conditions. There was no growth anaerobically. Gram staining showed irregularly staining organisms with slightly tapered ends. The subcultures of both blood cultures had adequate growth on the sheep blood agar plate but only a slight haze on MacConkey and chocolate agar plates after 24 h. The catheter tip initially produced growth on both colistin-nalidixic acid agar and chocolate agar that was identified as S. aureus, which was consistent with the patient's blood cultures. After 48 h, there were pinpoint, dark pink colonies on MacConkey agar and medium-sized white colonies on chocolate agar.

The Vitek 2 compact system identified each isolate as Cupriavidus pauculus at the 98% confidence level. However, sensitivities were not reported due to the lack of correlation studies of MICs for this particular organism. The bacteria could not be definitively coded by the bioMérieux API 20E system. Acidovorax was not included in either compendium. Additional tests performed on the isolate included oxidase (positive), catalase (negative), nitrate (positive), and indole (negative). Etest antibiotic susceptibility testing for gentamicin yielded an MIC of 2.0 μg/ml. MICs determined using Sensititre from Trek Diagnostics in Microbiology, CLS, Saint Francis Hospital, Hartford, CT, are shown in Table Table2.2. Gentamicin MIC was reported as intermediately sensitive at 8 μg/ml. Sequencing with 16S rRNA provided a 100% match over 485 nucleotides to an Acidovorax avenae type strain (ATCC 19860). Some of the closest genetic neighbors within the Comamonadaceae family include Comamonas, Rubrivivax, Hydrogenophaga, Aquaspirillum, Polaromonas, Variovorax, Xylophilus, and Brachymonas species (7), but they were less than 96.5% related to the isolate.

TABLE 2.
MICs for Acidovorax avenaea

Very few members of the Comamonadaceae family have been reported to cause infections in humans. However, most reports that exist are of cases due to Comamonas acidovorans or Comamonas testosteroni. Both organisms are known for producing ocular infections (11, 12, 15, 17, 22), endocarditis (4, 9), nosocomial pneumonia (6), bacteremia (8, 10, 19, 20), and central line-associated bloodstream infections (1, 2, 5, 13). There was also one report of bacteremia due to Comamonas terrigena in the literature (21).

Acidovorax avenae is a non-lactose-fermenting, oxidase-positive, aerobic, nonpigmented GNR (14, 16). These organisms are found in soil and water and are also recognized as plant pathogens. This bacterium infects a wide range of plants, including corn, rice, watermelon, pumpkins, and orchids. It often manifests as a seedling disease with brown stripes forming on the plant sheaths (18). The medical literature contains a case of A. avenae bloodstream infection involving a peripheral venous catheter as the potential source of entry (18). The individual was on long-term steroid therapy for sarcoidosis and was treated with 7 days of ciprofloxacin. A second case describes A. avenae bacteremia in a neutropenic patient with non-Hodgkin's lymphoma. However, information on antibiotic therapy was not provided (23).

Our patient appeared to suffer sepsis caused by two different organisms, A. avenae and MSSA. We were surprised by the finding of A. avenae and its apparent pathogenicity. Initial blood cultures did not demonstrate any GNRs, and therapy was targeted only at MSSA with daptomycin and cefazolin. As the patient remained febrile despite this therapy, follow-up blood cultures were collected. These showed eradication of MSSA with the new finding of a GNR. We believe that both organisms were responsible for the patient's sepsis because of failure to improve on targeted MSSA treatment alone.

We surmise that MSSA overgrew A. avenae initially because of a higher growth rate, as A. avenae was found only when MSSA was eradicated. To test this hypothesis, we performed blood culture and comparative growth studies. We used the original A. avenae isolate and also S. aureus ATCC 29213, which had a sensitivity pattern similar to that of the patient's strain.

Blood culture bottles were spiked with pure cultures of either A. avenae, MSSA, or a 50/50 mixture of the two organisms. Six milliliters of 0.45% saline in a suspension at a McFarland standard of 0.60 was used. The MSSA and the combined A. avenae-MSSA bottles turned positive at 5 h 13 min (both Gram stains showed GPC). The A. avenae bottle turned positive at 9 h 27 min (Gram stain showed GNRs). The combined A. avenae-MSSA bottle was reincubated and Gram stained after 20 h. This demonstrated both GPC and GNRs.

Comparative growth studies were performed at 27 and 37°C (Table (Table3).3). Three different media were used to plate A. avenae including MacConkey, chocolate, and blood agar plates. The organism demonstrated better growth at 37°C, and yet growth rates were still much lower than those of MSSA (data not shown). These findings support our assertion that Acidovorax avenae was initially missed because of the MSSA overgrowth.

TABLE 3.
Comparative growth studies for Acidovorax avenae

The antibiogram for A. avenae supports this selection hypothesis. Culture of the port catheter demonstrated MSSA and A. avenae, suggesting that both organisms were relevant. Since there were no CLSI breakpoints for A. avenae, breakpoints were taken from MIC interpretive standards for other non-Enterobacteriaceae for the Etest and Sensititre methods (3). There was an obvious discrepancy between the Etest and Sensititre gentamicin MICs, which were 2 and 8 μg/ml, respectively. Repeat Etest performance confirmed the lower MIC. Fortunately, the addition of gentamicin led to a clinical improvement and the patient defervesced. The remainder of the hospital course was uneventful, and device removal coupled with 14 days of antibiotic treatment led to a successful clinical outcome.

Acidovorax infections in humans are rare. There is little information regarding clinical epidemiology, pathogenicity, or approach to treatment. One reported case of Acidovorax infection utilized ciprofloxacin for successful treatment (18). Treatment in the other case was not specified. To our knowledge, this is the third documented case of A. avenae-related bacteremia.

In this case, gentamicin proved effective. Antibiotic sensitivity testing of the GNR isolate by Etest provided rapid clinically useful information. This simple test allowed direct visualization of the effect of gentamicin on the organism's growth. We advocate at a minimum this type of testing in lieu of more advanced tests, particularly if the patient's course is not improving.

Our hospital laboratory initially missed the etiologic diagnosis of this GNR infection. The isolation of unusual bacteria on automated bacterial identification systems should raise suspicions about accuracy. Sequencing of 16S RNA with BLAST analysis yielded the identity of the causative organism—Acidovorax avenae—in this case. When clinical conditions mandate, we advocate a thorough diagnostic approach.

Footnotes

[down-pointing small open triangle]Published ahead of print on 26 August 2009.

REFERENCES

1. Castagnola, E., M. Conte, P. Venzano, A. Garaventa, C. Viscoli, M. A. Barretta, L. Pescetto, L. Tasso, M. Nantron, C. Milanaccio, and R. Giacchino. 1997. Broviac catheter-related bacteraemias due to unusual pathogens in children with cancer: case reports with literature review. J. Infect. 34:215-218. [PubMed]
2. Castagnola, E., L. Tasso, M. Conte, M. Nantron, A. Barretta, and R. Giacchino. 1994. Central venous catheter-related infection due to Comamonas acidovorans in a child with non-Hodgkin's lymphoma. Clin. Infect. Dis. 19:559-560. [PubMed]
3. Clinical and Laboratory Standards Institute. 2008. Performance standards for antimicrobial susceptibility testing, 18th informational supplement. CLSI document M100-S18. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Cooper, G. R., E. D. Staples, K. A. Iczkowski, and C. J. Clancy. 2005. Comamonas (Pseudomonas) testosteroni endocarditis. Cardiovasc. Pathol. 14:145-149. [PubMed]
5. Ender, P. T., D. P. Dooley, and R. H. Moore. 1996. Vascular catheter-related Comamonas acidovorans bacteremia managed with preservation of the catheter. Pediatr. Infect. Dis. J. 15:918-920. [PubMed]
6. Franzetti, F., M. Cernuschi, R. Esposito, and M. Moroni. 1992. Pseudomonas infections in patients with AIDS and AIDS-related complex. J. Intern. Med. 231:437-443. [PubMed]
7. Grabovich, M., E. Gavrish, J. Kuever, A. M. Lysenko, D. Podkopaeva, and G. Dubinina. 2006. Proposal of Giesbergeria voronezhensis gen. nov., sp. nov. and G. kuznetsovii sp. nov. and reclassification of [Aquaspirillum] anulus, [A.] sinuosum and [A.] giesbergeri as Giesbergeria anulus comb. nov., G. sinuosa comb. nov. and G. giesbergeri comb. nov., and [Aquaspirillum] metamorphum and [A.] psychrophilum as Simplicispira metamorpha gen. nov., comb. nov. and S. psychrophila comb. nov. Int. J. Syst. Evol. Microbiol. 56:1179. [PubMed]
8. Gul, M., P. Ciragil, E. Bulbuloglu, M. Aral, S. Alkis, and F. Ezberci. 2007. Comamonas testosteroni bacteremia in a patient with perforated acute appendicitis. Acta Microbiol. Immunol. Hung. 54:317-321. [PubMed]
9. Horowitz, H., S. Gilroy, S. Feinstein, and G. Gilardi. 1990. Endocarditis associated with Comamonas acidovorans. J. Clin. Microbiol. 28:143-145. [PMC free article] [PubMed]
10. Lair, M. I., S. Bentolila, D. Grenet, P. Cahen, and P. Honderlick. 1996. Oerskovia turbata and Comamonas acidovorans bacteremia in a patient with AIDS. Eur. J. Clin. Microbiol. Infect. Dis. 15:424-426. [PubMed]
11. Lee, S. M., M. K. Kim, J. L. Lee, W. R. Wee, and J. H. Lee. 2008. Experience of Comamonas acidovorans keratitis with delayed onset and treatment response in immunocompromised cornea. Korean J. Ophthalmol. 22:49-52. [PMC free article] [PubMed]
12. Lema, I., M. Gómez-Torreiro, and M. T. Rodríguez-Ares. 2001. Comamonas acidovorans keratitis in a hydrogel contact lens wearer. CLAO J. 27:55-56. [PubMed]
13. Le Moal, G., M. Paccalin, J. P. Breux, F. Roblot, P. Roblot, and B. Becq-Giraudon. 2001. Central venous catheter-related infection due to Comamonas testosteroni in a woman with breast cancer. Scand. J. Infect. Dis. 33:627-628. [PubMed]
14. LiPuma, J. J., B. J. Currie, G. D. Lum, and P. A. R. Vandamme. 2007. Burkholderia, Stenotrophomonas, Ralstonia, Cupriavidus, Pandoraea, Brevundimonas, Comamonas, Delftia, and Acidovorax, p. 749-769. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. L. Landry, and M. A. Pfaller (ed.), Manual of clinical microbiology, 9th ed. ASM Press, Washington, DC.
15. Miño de Kaspar, H., T. Grasbon, and A. Kampik. 2000. Automated surgical equipment requires routine disinfection of vacuum control manifold to prevent postoperative endophthalmitis. Ophthalmology 107:685-690. [PubMed]
16. Potnikova, E., and N. Schaad. 2008. Identification, molecular characterization, and detection of foreign and newly emerging domestic bacteria. United States Department of Agriculture, Washington, DC. http://www.ars.usda.gov/research/publications/Publication.htm?seq. Accessed 4 February 2009.
17. Reddy, A. K., S. I. Murthy, S. Jalali, and U. Gopinathan. 2009. Post-operative endophthalmitis due to an unusual pathogen, Comamonas testosteroni. J. Med. Microbiol. 58:374-375. [PubMed]
18. Shetty, A., R. A. Barnes, B. Healy, and P. Groves. 2005. A case of sepsis caused by Acidovorax avenae. J. Clin. Infect. 51:e171-e172. [PubMed]
19. Siebor, E., C. Llanes, I. Lafon, A. Ogier-Desserrey, J. M. Duez, A. Pechinot, D. Caillot, M. Grandjean, N. Sixt, and C. Neuwirth. 2007. Presumed pseudobacteremia outbreak resulting from contamination of proportional disinfectant dispenser. Eur. J. Clin. Microbiol. Infect. Dis. 26:195-198. [PubMed]
20. Smith, M. D., and J. D. Gradon. 2003. Bacteremia due to Comamonas species possibly associated with exposure to tropical fish. South. Med. J. 96:815-817. [PubMed]
21. Sonnenwirth, A. C. 1970. Bacteremia with and without meningitis due to Yersinia enterocolitica, Edwardsiella tarda, Comamonas terrigena, and Pseudomonas maltophilia. Ann. N. Y. Acad. Sci. 174:488-502. [PubMed]
22. Stonecipher, K. G., H. G. Jensen, P. R. Kastl, A. Faulkner, and J. J. Rowsey. 1991. Ocular infections associated with Comamonas acidovorans. Am. J. Ophthalmol. 112:46-49. [PubMed]
23. Xu, J., J. E. Moore, B. C. Millar, H. D. Alexander, R. McClurg, T. C. M. Morris, and P. J. Rooney. 2004. Improved laboratory diagnosis of bacterial and fungal infection in patients with hematological malignancies using PCR and ribosomal RNA sequence analysis. Leuk. Lymphoma 45:1637-1641. [PubMed]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)